Daniel A. Barocas, MD

Vanderbilt University Medical Center

Daniel A. Barocas, MD, MPH, FACS is Professor and Executive Vice Chair of Urologic at the Vanderbilt University Medical Center, and the Vanderbilt Ingraham Cancer Center. He has clinical and research interests in urologic cancers, particularly in the detection and treatment of localized cancers, and the measurement of patient outcomes and quality of care. Dr. Barocas has received grants from NIH to study active surveillance for prostate cancer care, and to study variation in the evaluation of hematuria. He is currently PI of the CEASAR study (Comparative Effectiveness Assessment of Surgery And Radiation), funded by NCI to study oncologic and patient-reported outcomes in a large prospective, population-based cohort study. In addition to his activities as a urologic oncologist and health services researcher, Dr. Barocas is involved with national organizations, including the American Urological Association and Commission on Cancer, and in development of quality measures for urologic cancer care.

Disclosure information not submitted.

Presentation(s):

• 021IC - A Case-Based Approach to the Evaluation and Management of Urinary Tract Bleeding: Navigating AUA Microhematuria Guidelines to Intractable Hemorrhagic Cystitis

  Friday, April 28, 2023
  4:00 PM – 6:00 PM CST

• 048IC - Prostate Cancer Diagnosis: AUA Guidelines on use of PSA, Biomarkers, MRI and Biopsy Techniques

  Sunday, April 30, 2023
  7:30 AM – 9:30 AM CST

• PD39: Prostate Cancer: Detection & Screening V

  Monday, May 1, 2023
  7:00 AM – 9:00 AM CST